Inspira Technologies OXY B.H.N. Ltd. (IINN) Stock
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Inspira Technologies OXY B.H.N. Ltd. is led by CEO Dagi Shahar Ben-Noon, employs 37 people, headquartered in IL, publicly traded since 2021.
Inspira Technologies OXY B.H.N. Ltd. (IINN) stock trades at $1.26 with a market capitalization of $30.34M. The stock is valued at a price-to-earnings (P/E) ratio of -2.80, price-to-book of 15.17, price-to-sales of 92.25. Over the past 52 weeks the stock has ranged between $0.33 and $2.10, and currently trades 40.0% below its 52-week high.
On profitability, Inspira Technologies OXY B.H.N. Ltd. generates a return on equity (ROE) of -650.00%, return on capital employed of -700.00%, a net profit margin of -22.14%.
Official website: inspira-technologies.com